Clinical trials for the verification of safety and efficiency of tamibarotene for the treatment of Alzheimer's disease
Phase 2
Completed
- Conditions
- Alzheimer's disease
- Registration Number
- JPRN-jRCT2090220288
- Lead Sponsor
- Fumihiko Yasuno
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
The patients of Alzheimer's disease with mild and moderate cognitive disfunction(15<MMSE score<27)
Exclusion Criteria
The use of other drugs of clinical trials
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognitive function scores (ADAS-JCog, MMSE, CIBIC-plus, ADCS-ADL)and safety
- Secondary Outcome Measures
Name Time Method